NFKB1 and cancer: ITCs induce cell cycle arrest, cancer cell apoptosis [146], generation of reactive oxygen species (ROS) [145, 147], regulate the activation of transcription factors STAT3, NF-kB and Nrf2 [148-150], inhibit MAPK and PKC activities [145, 151], down-regulate estrogen receptor [152].